Structure Based Antibody-Like Peptidomimetics
Biologics such as monoclonal antibodies (mAb) and soluble receptors represent new classes of therapeutic agents for treatment of several diseases. High affinity and high specificity biologics can be utilized for variety of clinical purposes. Monoclonal antibodies have been used as diagnostic agents...
Main Authors: | Mark I. Greene, Ramachandran Murali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-02-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/5/2/209/ |
Similar Items
-
Peptidomimetics Therapeutics for Retinal Disease
by: Dylan E. Parsons, et al.
Published: (2021-02-01) -
Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery
by: Adina Borbély, et al.
Published: (2019-06-01) -
Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting
by: Lizeth Bodero, et al.
Published: (2018-02-01) -
Peptidomimetics in cancer targeting
by: Mohammad Mahmoudi Gomari, et al.
Published: (2022-12-01) -
Short Cationic Peptidomimetic Antimicrobials
by: Rajesh Kuppusamy, et al.
Published: (2019-04-01)